Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Angola

Type of support

Approvals

2001-2021 (US$)

(23 Aug 2017)

Commitments

2001-2021 (US$)

(23 Aug 2017)

Disbursements

2000-2017 (US$)

(23 Aug 2017)

% Disbursed

(23 Aug 2017)

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

Total

$113,194,911

$113,194,911

$110,938,525

Graduation grant (GG)

$1,463,052

$1,463,052

$1,235,822

84%

Health system strengthening (HSS 1)

$3,969,999

$3,969,999

$2,920,109

74%

Immunisation services support (ISS)

$2,988,000

$2,988,000

$2,988,000

100%

Injection Safety Devices (NVS)

$391,500

$391,500

$495,190

126%

Injection safety support (INS)

$1,252,610

$1,252,610

$1,252,610

100%

IPV (NVS)

$1,688,501

$1,688,501

$103,076

6%

MR-Catch-up campaign (NVS)

$4,554,500

$4,554,500

$4,600,651

101%

Penta (NVS)

$54,736,377

$54,736,377

$55,040,963

101%

Pneumo (NVS)

$30,266,817

$30,266,817

$31,454,165

104%

Rotavirus (NVS)

$8,139,555

$8,139,555

$8,221,439

101%

Vaccine Introduction Grant (VIG)

$3,744,000

$3,744,000

$2,626,500

70%

Red line on table indicates duration of support based on commitments.Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.Approvals: Total Approved for funding

News and updates relating to Angola

Ahead of Seth Berkley’s speech to the 2017 graduating class at Johns Hopkins University in Washington, DC on 23 June, Global Health published a two-part Q&A with the Gavi CEO. In this first article, Seth describes Gavi’s latest priorities, highlights the increased risk of epidemics starting in densely populated urban slums and emphasises the need to reach every child with all WHO-recommended vaccines.

Ahead of Seth Berkley’s speech to the 2017 graduating class at Johns Hopkins University in Washington, DC on 23 June, Global Health published a two-part Q&A with the Gavi CEO. In this second article, Seth shares his concerns about the expansion of the vaccine hesitancy movement, explains why digital identity technologies in low- and middle-income countries can help improve vaccine coverage, and discusses the value of testing the potentially important malaria vaccine.

New data released by the World Health Organization (WHO) for the Measles & Rubella Initiative, estimates that 17.1 million lives have been saved since 2000, largely due to increased vaccination coverage against this highly contagious viral disease.